SAC Capital Slashes Stake in Intercept Pharmaceuticals (ICPT) to Near 0%

In an amended 13G filing on Intercept Pharmaceuticals (NASDAQ: ICPT), Steven Cohen's hedge fund SAC Capital disclosed a 0.03%, or 6,123 share, stake in the company. This is down 99.55% from the 1,369,046 shares held at the end of the latest quarter.

For more notable holders of Intercept Pharmaceuticals stock click here. For more information on SAC Capital click here.

You May Also Be Interested In

• Lazard AUM rises to $290.3 billion at end of August 2026
• Blackstone to acquire data center cooling firm Flow Control Holdings
• Shutterstock adds three members to its board of directors